$康方生物(09926)$ $Summit Therapeutics(SMMT)$ #创新药#
1L EGFRwt sq非小在ELCC似乎要更新一些新的数据了？
Title：Phase 2 Results of Ivonescimab a Novel PD-1/VEGF Bispecific in Combination with Chemotherapy for First Line Treatment of Patients with Advanced / Metastatic Squamous Non-Small Cell Lung Cancer
Link：网页链接